Milestone Pharmaceuticals Inc.
Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $0.41
- 52-Week Range
- $0.36 – $3.06
- Market Cap
- $57.32M
- P/E (TTM)
- —
- EPS (TTM)
- -0.74
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.35
- PEG Ratio
- —
- Return on Equity
- -1370.55%
- Return on Assets
- -45.72%
- Gross Margin
- 93.01%
- Operating Margin
- -1726.39%
- Profit Margin
- 0.00%
- Current Ratio
- 6.27
- Debt/Equity
- —
- Total Debt
- $143.77M
- Free Cash Flow
- $-53.52M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $55.73M
Market Snapshot
About
Milestone Pharmaceuticals is a biopharmaceutical company developing treatments for cardiovascular conditions, particularly cardiac arrhythmias. The company focuses on therapies for paroxysmal supraventricular tachycardia and other heart rhythm disorders.